Evidence map›Paper›PMID 19287048›Full record

ReviewCardiovascular research2009

Regulation of vascular physiology and pathology by the S1P2 receptor subtype.

Athanasia Skoura, Timothy Hla

Open access · bronzeAbstract readReview
In one paragraph

Review in Cardiovascular research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 97 citations in OpenAlex.

  1. Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Pharmacological sphingosine-1 phosphate receptor 1 targeting in cigarette smoke-induced emphysema in mice.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Athanasia SkouraCenter for Vascular Biology, University of Connecticut Health Center, Farmington, CT 06030-3501, USA.
Timothy Hla
UConn Health · US

Funding

Post-Transcriptional Mechanisms and Vascular InflammationR01HL049094 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HLA, TIMOTHY TUN · 1993 to 2013
$4.2M
Sphingolipid modulators of vascular growth & homeostasisR37HL067330 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HLA, TIMOTHY TUN · 2006 to 2015
$3.9M
Sphingosine 1-phosphate receptors in vascular homeostasis and pathologyR01HL089934 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HLA, TIMOTHY TUN · 2008 to 2016
$3.3M
Sphingolipid modulators of vascular growth &homeostasisR01HL067330 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HLA, TIMOTHY TUN · 2001 to 2005
$1.6M
NHLBI NIH HHS HL67330NHLBI NIH HHS HL89934NHLBI NIH HHS R01-HL49094
6 · The paper itself

Abstract

Sphingosine-1-phosphate (S1P) is now recognized as a lipid mediator that acts via G-protein-coupled receptors. S1P receptors couple to various heterotrimeric G-proteins and regulate downstream targets and ultimately cell behaviour. The prototypical S1P1 receptor is known to couple to Gi and regulates angiogenesis, vascular development, and immune cell trafficking. In this review, we focus our attention on the S1P2 receptor, which has a unique G-protein-coupling property in that it preferentially activates the G(12/13) pathway. Recent studies indicate that the S1P2 receptor regulates critical intracellular signalling pathways, such as Rho GTPase, the phosphatase PTEN, and VE-cadherin-based adherens junctions. Analysis of mutant mice has revealed the critical role of this receptor in inner ear physiology, heart and vascular development, vascular remodelling, and vascular tone, permeability, and angiogenesis in vertebrates. These studies suggest that selective modulation of S1P2 receptor function by pharmacological tools may be useful in a variety of pathological conditions.

Indexed as

AnimalsBlood VesselsCardiovascular DiseasesDisease Models, AnimalGTP-Binding ProteinsHumansMiceNeovascularization, PathologicReceptors, LysosphingolipidSignal TransductionGTP-Binding ProteinsReceptors, Lysosphingolipid

Identifiers

PMID19287048
PMCPMC2721650
OpenAlexW2162708115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.